I
I

Investec

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

South Africa's rand firms as dollar retreats from 20-year high

JOHANNESBURG, May 17 (Reuters) - South Africa's rand firmed on Tuesday, as a pullback in the U.S. dollar offered support despite continued power cuts that cloud the domestic economic growth outlook. At 1501 GMT, the rand ZAR=D3 traded at 15.9450 against the dollar, 1.28% firmer than its previous close. The dollar =USD fought for a footing after fal
I
U

Caution rules U.S. stock market ahead of Fed policy decision

Jan 25 (Reuters) - Investors are wary of rushing to scoop up stocks ahead of a highly anticipated Federal Reserve policy decision due on Wednesday, and Monday's bounce has done little to dispel concerns about the market's outlook. In a rare reversal, Wall Street recovered from a steep sell-off on Monday to close higher on the day with the help of r
I
M
U
U
U

Retail investors bought $1.36 bln in stocks on Jan 24

MILAN, Jan 25 (Reuters) - Retail investors bought a net $1.36 billion in equities on Monday when interest rate jitters and geopolitical tensions sending world stocks on track for its biggest monthly drop since the pandemic hit markets in March 2020, data from Vanda Research showed on Tuesday. That is the highest level since Jan. 18 when net purchas
I
M
U
U

FTSE 100 falls as commodity-related stocks weigh, Playtech jumps on takeover bid

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * FTSE 100 down 0.3%, FTSE 250 flat Nov 18 (Reuters) - UK's FTSE 100 fell on Thursday as oil and mining majors took a hit from weaker commodity prices, while online gambling software developer Playtech jumped after receiving a third takeover
I
U

UK Stocks-Factors to watch on Nov. 18

Nov 18 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower with futures down 0.18% FFIc1 on Thursday. * ASTRAZENECA: AstraZeneca AZN.L said its COVID-19 antibody drug was 83% effective in cutting the risk of people contracting symptomatic illness in a six-month follow-up study. * METRO BANK: U.S. private equity firm Carlyle CG.O and Me
A
I
M
N
R
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.